Forest Laboratories, Inc. Presents Data of COPD Therapy Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast
COPD, News
Forest Laboratories, Inc., a New York-based pharmaceutical company, announced that it will present data on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), a combination use of aclidinium bromide/formoterol fumarate, and DALIRESP ... Read more